Teleflex stock kpis
Want to see TFX full AI Analyst Report?
Revenue by Segment
Highlights income from different business units, showcasing which segments drive growth and profitability, and indicating strategic focus areas.
Vascular Access and Surgical are the steady, reliable growth engines while Interventional has become lumpy—spiking with the VI acquisition but then showing integration‑related volatility that pressured near‑term guidance and margins. The abrupt disappearances in OEM/Other/Anesthesia/Interventional Urology reflect the OEM divestiture and reclassification: that reduces recurring revenue but materially strengthened the balance sheet, enabled buybacks/debt paydown, and helps explain management’s upgraded EPS outlook despite tighter 2026 revenue guidance; margin recovery is expected in 2027 as synergies and restructuring kick in.
TFX Revenue by Segment
| Date | Other | Interventional | Vascular Access | Anesthesia | Surgical | Interventional Urology | OEM |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.00 | $210.30M | $243.45M | $0.00 | $114.03M | $0.00 | $0.00 |
| Jun 30, 2026 | $0.00 | $211.87M | $246.34M | $0.00 | $112.12M | $0.00 | $0.00 |
| Mar 31, 2026 | $0.00 | $204.66M | $236.81M | $0.00 | $106.79M | $0.00 | $0.00 |
| Dec 31, 2025 | $0.00 | $217.90M | $240.20M | $0.00 | $110.50M | $0.00 | $0.00 |
| Sep 30, 2025 | $79.08M | $266.41M | $191.02M | $101.45M | $122.88M | $71.77M | $80.41M |
| Jun 30, 2025 | $59.90M | $170.00M | $185.50M | $96.40M | $114.00M | $76.40M | $78.70M |
| Mar 31, 2025 | $53.50M | $137.50M | $182.40M | $86.60M | $105.80M | $71.00M | $63.90M |
| Dec 31, 2024 | $58.20M | $160.40M | $189.30M | $95.30M | $121.90M | $84.90M | $85.40M |
| Sep 30, 2024 | $54.80M | $149.90M | $180.90M | $101.10M | $111.70M | $83.40M | $82.60M |
| Jun 30, 2024 | $41.70M | $141.20M | $181.10M | $102.50M | $111.30M | $83.10M | $88.80M |
| Mar 31, 2024 | $52.40M | $134.70M | $181.40M | $96.40M | $105.50M | $79.70M | $87.70M |
| Dec 31, 2023 | $68.20M | $135.60M | $186.70M | $98.20M | $109.60M | $93.00M | $82.60M |
| Sep 30, 2023 | $76.10M | $134.10M | $169.90M | $97.60M | $112.80M | $73.60M | $82.30M |
| Jun 30, 2023 | $76.00M | $124.80M | $173.80M | $100.80M | $106.00M | $77.80M | $84.10M |
| Mar 31, 2023 | $71.60M | $116.90M | $177.70M | $93.30M | $99.00M | $75.40M | $77.00M |
| Dec 31, 2022 | $73.60M | $125.10M | $186.40M | $99.60M | $110.40M | $89.20M | $73.70M |
| Sep 30, 2022 | $69.90M | $108.70M | $167.10M | $97.60M | $93.10M | $79.00M | $71.30M |
| Jun 30, 2022 | $72.10M | $114.40M | $163.90M | $104.70M | $99.60M | $79.80M | $70.00M |
| Mar 31, 2022 | $69.50M | $96.90M | $166.10M | $86.90M | $89.70M | $74.90M | $57.70M |
| Dec 31, 2021 | $84.70M | $114.90M | $193.00M | $102.80M | $106.40M | $92.90M | $67.20M |
| Sep 30, 2021 | $83.40M | $104.30M | $175.50M | $97.10M | $92.80M | $83.10M | $64.10M |
| Jun 30, 2021 | $86.90M | $112.10M | $167.70M | $95.40M | $98.20M | $92.20M | $61.00M |
| Mar 31, 2021 | $81.70M | $96.20M | $164.00M | $84.90M | $80.40M | $73.40M | $53.50M |
| Dec 31, 2020 | $98.10M | $106.70M | $182.50M | $86.10M | $92.30M | $93.90M | $51.70M |
| Sep 30, 2020 | $86.00M | $93.20M | $160.00M | $75.70M | $82.20M | $81.80M | $49.40M |
| Jun 30, 2020 | $91.40M | $82.60M | $164.90M | $64.90M | $67.30M | $40.10M | $55.80M |
| Mar 31, 2020 | $91.70M | $99.90M | $150.30M | $75.70M | $75.40M | $74.20M | $63.40M |
| Dec 31, 2019 | $89.40M | $112.70M | $154.60M | $85.30M | $95.20M | $89.10M | $54.60M |
| Sep 30, 2019 | $83.90M | $106.90M | $148.70M | $87.10M | $92.60M | $73.60M | $55.40M |
| Jun 30, 2019 | $88.40M | $104.80M | $153.60M | $85.70M | $85.70M | $68.00M | $56.40M |
| Mar 31, 2019 | $85.60M | $103.20M | $143.90M | $80.30M | $86.70M | $59.70M | $54.20M |
